Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia
Clinical trial NCT03230071 · COMPLETED
Trial details
- NCT number
- NCT03230071
- Sponsor
- Dongzhimen Hospital, Beijing
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-28
- Primary completion
- 2019-08-22
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.